Toggle Nav
Close
  • Menu
  • Setting

EZ Cap™ Mouse IL-23 mRNA (m1Ψ, HA tag)

Catalog No.
R1067
Mouse IL-23 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
Grouped product items
SizePriceStock Qty
100ug (1mg/mL)
$210.00
In stock
1mg (1mg/mL)
$1,136.00
In stock
5x1mg (1mg/mL)
$4,090.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

IL-23 (Interleukin-23) is an important cytokine belonging to the IL-12 cytokine family. It consists of two subunits, IL-23 p19 and IL-12 p40, and is mainly secreted by dendritic cells and macrophages. IL-23 plays an important role in regulating and maintaining the differentiation and function of Th17 cells. Th17 cells are a subtype of helper T cells that are primarily involved in defending against bacterial and fungal infections.

IL-23, by binding to its specific receptor IL-23R, activates downstream signaling pathways, including the JAK-STAT signaling pathway, to promote inflammation. Because of its importance in inflammatory and autoimmune diseases, IL-23 is a potential target for the treatment of a variety of diseases, such as psoriasis, Crohn's disease, and multiple sclerosis. In recent years, biologics targeting IL-23, such as monoclonal antibodies, have been developed for clinical treatment, showing good efficacy and safety.

EZ Cap™ Mouse IL-23 mRNA (m1Ψ, HA tag) is provided at a concentration of ~1 mg/ml with Cap1 structure. It expresses Mouse IL-23 cytokine with HA label, which is convenient for the subsequent detection of protein expression. There are currently two ways to cap mRNA: One is co-transcription method, by adding Cap analogues into the transcription process. The other is enzymatic Capping. After transcription, Cap0 capping is performed by Vaccinia virus Capping Enzyme (VCE), GTP and S-adenosylmethionine (SAM). The Cap0 is then generated into the Cap1 through 2´-O-Methyltransferase and SAM. Cap1 Capping can also be performed by adding VCE, 2´-O-Methyltransferase, GTP and SAM in a one-step process. Cap 1 structure is more ideal for mammalian systems and possess higher transcription efficiency than Cap 0 structure. The addition of N1-Methylpseudo-UTP(m1Ψ) and poly(A) tail suppress RNA-mediated innate immune activation and increase the stability and lifetime of the mRNA in vitro and in vivo. Poly(A) tail also plays an important role in enhancing the efficiency of translation initiation.

Quality Control

Quality Control & MSDS

View current batch:
 

Description

mRNA Length

1821 nucleotides

Concentration

~1 mg/mL

Buffer

1 mM Sodium Citrate, pH 6.4

Storage

-40°C or below

General tips

Please dissolve it on ice and protect from RNase carefully. Avoid repeated freeze/thaw cycles as possible. Don’t vortex. Upon first use, centrifuge the tube softly and aliquot it into several single use portions. Use RNase-free reagents and materials with appropriate RNase-free technique. Don’t add to the media with serum unless mixing with a transfection reagent.

Shipping Condition

ship with dry ice